Condition

Renal Cell Carcinoma Metastatic clinical trials and research

• 7Clinical trials
• 8Countries

Newest Renal Cell Carcinoma Metastatic clinical trials

All recruiting trials (7)

• OM-RCA-01 (anti-FGFR1 antibody) for metastatic tumors that express FGFR1

  This trial will try OM-RCA-01, an IV antibody given every two weeks, in adults with metastatic cancers whose tumors test positive for FGFR1 and who have progressed after standard treatments.

  Recruiting at 4 sites Phase 1/2 Kidney Cancer Research Bureau · Kazan' and 4 other locations · NCT07292168

• High-dose radiotherapy for renal cell carcinoma treatment

  This study is testing whether a higher dose of radiation therapy can be a better option for people with kidney cancer compared to the standard treatment.

  Recruiting Royal Marsden NHS Foundation Trust · London · NCT06995664

• Combining systemic therapy with stereotactic body radiotherapy for kidney cancer with limited spread

  This study is testing if adding a special type of radiation therapy to standard treatment can help people with kidney cancer that has spread a little bit live longer and feel better.

  Recruiting at 8 sites Phase 3 Sun Yat-sen University · Fuzhou, Fujian and 8 other locations · NCT06726421

• Evaluating JMKX003948 Tablets for Patients with Renal Cell Carcinoma

  This study is testing a new tablet called JMKX003948 to see if it is safe and effective for people with advanced kidney cancer.

  Recruiting Phase 1 Jemincare · Beijing · NCT06321250

• Evaluating decision aids for patients with renal cell carcinoma

  This study is testing two decision aids to see if they can help patients with renal cell carcinoma make better treatment choices and feel more confident about their decisions.

  Recruiting St. Antonius Hospital · Nieuwegein, Utrecht · NCT05548621

• Monitoring drug levels to improve outcomes in metastatic kidney cancer patients

  This study is testing how monitoring drug levels and certain genetic factors can help improve treatment outcomes for people with metastatic kidney cancer.

  Recruiting University of Aarhus · Aarhus, Danmark · NCT04659343

• Deferred surgery for kidney cancer with metastases

  This study is testing whether waiting to do kidney surgery after starting treatment for kidney cancer with metastases can help patients live longer compared to having surgery right away.

  Recruiting at 11 sites University of Aarhus · Aarhus, Central Region of Denmark and 10 other locations · NCT03977571

Related topics

Quick answers

How many Renal Cell Carcinoma Metastatic clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in China (2 trials), Denmark (2 trials), Netherlands (1 trial), United Kingdom (1 trial), Finland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →